Nur Ink Innovations Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
NURI
IL0011757288
Specialty Chemicals
Sales 2022 | - | Sales 2023 | - | Capitalization | 53.72M 198M 4.21B |
---|---|---|---|---|---|
Net income 2022 | -11M -40.46M -863M | Net income 2023 | -12M -44.14M -941M | EV / Sales 2022 | - |
Net cash position 2022 | 17.77M 65.35M 1.39B | Net cash position 2023 | 7.22M 26.58M 567M | EV / Sales 2023 | - |
P/E ratio 2022 |
-13.6
x | P/E ratio 2023 |
-
| Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 48.32% |
Managers | Title | Age | Since |
---|---|---|---|
Moshe Nur
CEO | Chief Executive Officer | 74 | 13/11/18 |
David Gerbi
DFI | Director of Finance/CFO | 44 | 25/01/21 |
Moshe Nakash
CTO | Chief Tech/Sci/R&D Officer | 60 | 08/03/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 01/09/19 | |
Sarel Ashkenazi
BRD | Director/Board Member | 51 | 25/01/21 |
Moshe Nur
CEO | Chief Executive Officer | 74 | 13/11/18 |
1st Jan change | Capi. | |
---|---|---|
+7.38% | 3.93B | |
+16.58% | 1.97B | |
+27.04% | 1.14B | |
+4.43% | 988M | |
+36.66% | 677M | |
+30.46% | 727M | |
+47.73% | 661M | |
-10.93% | 632M | |
+33.51% | 573M |